Lebenslauf
Facharzt für Allgemein- und Viszeralchirurgie
- 2024: Vorstand der Abteilung für Chirurgie mit Gefäßchirurgie und Plastischer Chirurgie im Göttlicher Heiland Krankenhaus Wien
- 2024: Abschuss des Leadership Curriculum an der Medizinischen Universität Wien (Meduni Wien)
- 2023: Abschluss Heathcare Management an der Wirtschaftsuniversität (MBA)
- 2022: Fellow of the American College of Surgeons (FACS)
- 2022: Fellow of the International Society of Surgery (F.I.S.S.)
- 2022: Tagungspräsident der 38. Jahrestagung der Österreichischen Gesellschaft für Onkologische Chirurgie (ACO-ASSO)
- 2021: Habilitation zum Privatdozent im Fach “Chirurgie”
- 2021: Abschluss Zertifikatsprogramm “Medizinische Lehre Wien” (MLW) der MedUni Wien
- 2020: Oberarzt an der Klinischen Abteilung für Allgemeinchirurgie der Universitätsklinik für Chirurgie
- 2019: Oberarzt an der Klinischen Abteilung für Transplantationschirurgie
- 2017: ACO ASSO Preisträger
- 2016: Ernennung zum Facharzt für Allgemeinchirurige
- 2014: Fellowship für chirurgische Onkologie der Österreichischen Gesellschaft für Onkologische Chirurgie (ACO-ASSO)
- 2013: Facharztprüfung für Allgemein- und Viszeralchirurgie
- 2012: Rotation an die Chirurgische Abteilung im Herz-Jesu Krankenhaus (Vinzenzgruppe)
- 2009: Facharztausbilung am Universitätsklinikum AKH Wien
- 2008: Präsenzdienst und Turnus für Innere Medizin – Heeresspital Wien
- 2006: Transplantkoordinator für Herz- und Lungentransplantation
- 2006: Studienabschluss der Humanmedizin an der Medizinischen Universität Wien
- 2000: Matura am Akademischen Gymnasium Linz
Mitgliedschaften
ÖGC (Österreichische Gesellschaft für Chirurgie)
ACO-ASSO (Österreichische Gesellschaft für Chirurgische Onkologie)
ESSO (European Society of Surgical Oncology)
EFS (European Foregut Society)
AFS (American Foregut Society)
ISS-SIC (International Society of Surgery)
ACS (American College of Surgery)
Gesellschaft der Chirurgen in Wien
ÖÄK-Diplome: DFP-Fortbildungsdiplom
Forschungsnetzwerk: ORCID 0000-0001-7119-8454
Research Profile MUW: Matthias Paireder
Wissenschaftliche Funktionen in Journalen
Editorial board:
European Surgery
Digestive Medical Research
Scientific Reviewer:
Clinical Nutrition, IF: 6,402
Cancers, IF: 6,126
Toxins, IF: 4,54
Langenbeck’s Archives of Surgery, IF: 3,445
BMC Cancer, IF: 3,150
Surgical Endoscopy, IF: 3,149
PLoS One, IF: 2,766
BMJ Open, IF: 2,496
Healthcare, IF: 1,916
Medicina, IF: 1,205
European Journal of Surgery, IF: 0,798
Wissenschaft und Publikationen
Platelets as a prognostic factor for patients with adenocarcinoma of the gastroesophageal junction
Feka J, Jomrich G, Winkler D, Ilhan-Mutlu A, Kristo I, Paireder M, Rieder E, Bologheanu M, Asari R, Schoppmann SF.
Langenbecks Archives 2023 Sep 6;408(1):351. doi: 10.1007/s00423-023-03093-y.
Preoperative BChE serves as prognostic marker in patients with resectable AEG after neoadjuvant chemotherapy
Gensthaler L, Jomrich G, Brugger J, Kollmann D, Paireder M, Bologheanu M, Riegler FM, Asari R, Schoppmann SF
Langenbecks Archives, 2023 Jun 6;408(1):227. doi: 10.1007/s00423-023-02938-w
GIST und Leiomyome des oberen Gastrointestinaltraktes
Paireder M, Schoppmann SF.
In: M. Kreis et al. (Hrsg.), Viszeral- und Allgemeinchirurgie, Springer Reference Medizin, Springer Nature 2022
Kontroverse: Schrittmacher im GI Trakt
Paireder M, Schoppmann SF.
JATROS, Infektiologie & Gastroenterologie-Hepatologie 3/22
Development of an alarm symptom-based risk prediction score for localized oesophagogastric adenocarcinoma (VIOLA score)
Puhr HC, Puhr R, Kuchiling DA, Jahic L, Takats J, Reiter T, Paireder M, Jomrich G, Schoppmann SF, Berghoff AS, Preusser M, Ilhan-Mutlu A.
ESMO Open 2022 Aug;7(4):100519. doi: 10.1016/j.esmoop.2022.100519. IF: 6,54
Tumor cell budding in preoperative biopsies of esophageal and gastroesophageal junction carcinoma independently predicts survival in a grade-dependent manner.
Beer A, Reber A, Paireder M, Schoppmann SF, Heber S, Schiefer AI.
Surgery. 2022 Apr 11:S0039-6060(22)00146-5. doi: 10.1016/j.surg.2022.02.020. IF: 3,98
Additional fundophrenicopexia, after Nissen fundoplication, reduces postoperative dysphagia and re-operation rate in the long-term follow up.
Nikolic M, Matic A, Kristo I, Paireder M, Asari R, Osmokrovic B, Semmler G, Schoppmann SF.
Surg Endosc. 2022 May;36(5):3019-3027. doi: 10.1007/s00464-021-08598-5. IF: 4,58
Esophageal resection in Austria—preparing a national registry.
Matthias Paireder, Reza Asari, Wolfgang Radlspöck, Anna Fabbri, Andreas Tschoner, Reinhold Függer, Johannes Zacherl, Sebastian F. Schoppmann. European Surgery volume 53, pages206–214 (2021). IF: 0,95
Meta-analysis of randomized controlled trials and individual patient data comparing minimally invasive with open oesophagectomy for cancer.
Müller-Stich BP, Probst P, Nienhüser H, Fazeli S, Senft J, Kalkum E, Heger P, Warschkow R, Nickel F, Billeter AT, Grimminger PP, Gutschow C, Dabakuyo-Yonli TS, Piessen G, Paireder M, Schoppmann SF, van der Peet DL, Cuesta MA, van der Sluis P, van Hillegersberg R, Hölscher AH, Diener MK, Schmidt T.
Br J Surg. 2021 Sep 27;108(9):1026-1033. doi: 10.1093/bjs/znab278. IF: 6,94
Thyroid Hormone Replacement Therapy Is Associated with Longer Overall Survival in Patients with Resectable Gastroesophageal Cancer: A Retrospective Single-Center Analysis.
Puhr HC, Reiter TJ, El-Mahrouk M, Saliternig L, Wolf P, Mair MJ, Steindl A, Paireder M, Asari R, Schoppmann SF, Berghoff AS, Preusser M, Ilhan-Mutlu A.
Cancers (Basel). 2021 Oct 9;13(20):5050. doi: 10.3390/cancers13205050. IF: 6,64
Effect of electrical stimulation therapy of the lower esophageal sphincter in GERD patients with ineffective esophageal motility.
Paireder M, Kristo I, Asari R, Jomrich G, Steindl J, Rieder E, Schoppmann SF.
Surg Endosc. 2020 Oct 30. doi: 10.1007/s00464-020-08104-3, IF: 3,149
Electrical stimulation therapy of the lower esophageal sphincter in GERD patients – a prospective single center study
Paireder M, Kristo I, Nikolic M, Jomrich G, Steindl J, Rieder E, Asari R, Schoppmann SF.
Eur Surg(2020). https://doi.org/10.1007/s10353-020-00678-5
Silent Gastroesophageal Reflux Disease in Patients with Morbid Obesity Trio to Metabolic Surgery
Kristo I, Paireder M, Jomrich G, Felsenreich DM, Fischer M, Hennerbichler FP, Langer FB, Prager G, Schoppmann SF.
Obes Surg, 2020 Sept 10; online ahead of print, IF: 3,412
Modification of preoperative radiochemotherapy for esophageal cancer (CROSS protocol) is safe and efficient with no impact on surgical morbidity
Paireder M, Jomrich G, Kristo I, Asari R, Rieder E, Beer A, Ilhan-Mutlu A, Preusser M, Schmid R, Schoppman SF.
Strahlenther Onkol, 2020 Feb13;196(9):779-786. IF: 2,717
Tailored modern GERD therapy – steps towards the development of an aid to guide personalized anti-reflux surgery.
Nikolic M, Schwameis K, Paireder M, Kristo I, Semmler G, Semmler L, Steindl A, Mosleh BO, Schoppmann SF.
Sci Rep, 2019 Dec16; 9(1),19174; IF: 4,122
Ineffective Esophageal Motility in Patients with GERD is no Contraindication for Nissen Fundoplication
Nikolic M, Schwameis K, Kristo I, Paireder M, Matic A, Semmler G, Semmler L, Schoppmann SF.
World J Surg, 2020 Jan; 44(1),186-193; IF: 2,768
High Systemic Immune-Inflammation Index is an Adverse Prognostic Factor for Patients With Gastroesophageal Adenocarcinoma
Jomrich G, Paireder M, Kristo I, Baierl A, Ilhan-Mutlu A, Preusser M, Asari R, Schoppmann SF.
Ann Surg, 2019 Aug 16;[online ahead of print], IF: 9,203
Modern Esophageal Function Testing and Gastroesophageal Reflux Disease in Morbidly Obese Patients
Kristo I, Paireder M, Jomrich G, Felsenreich DM, Nikolic M, Langer FB, Prager G, Schoppmann SF.
Obes Surg, 2019 Nov;29(11):3536-3541, IF: 3,603
High Mean Corpuscular Volume Predicts Poor Outcome for Patients With Gastroesophageal Adenocarcinoma.
Jomrich G, Hollenstein M, John M, Ristl R, Paireder M,Kristo I, Asari R, Schoppmann SF.
Ann Surg Oncol. 2019 Apr;26(4):976-985, IF: 3,857
Electrical lower esophageal sphincter augmentation in patients with GERD and severe ineffective esophageal motility – a safety and efficacy study
Paireder M,Kristo I, Asari R, Jomrich G, Steindl J, Rieder E, Schoppmann SF.
Surg Endosc 2019 Jan 22, doi: 10.1007/s00464-018-06649-y, IF: 3,747
Morbidity In Open Versus Minimally Invasive Hybrid Esophagectomy (MIOMIE) – Long-term results of a randomized controlled clinical study
Paireder M, Asari R, Kristo I, Rieder E, Zacherl J, Kabon B, Fleischmann E, Schoppmann SF.
Eur Surg 2018 Jul 11, doi: 10.1007/s10353-018-0552-y, IF: 0,349
Phenotypes of Jackhammer esophagus in patients with typical symptoms of gastroesophageal reflux disease responsive to proton pump inhibitors
Kristo I, Schwameis K, Maschke S, Kainz A, Rieder E, Paireder M, Jomrich G, Schoppmann SF.
Sci Rep. 2018 Jul 2;8(1):9949. doi: 10.1038/s41598-018-27756-9., IF: 4,122
Alternative therapies for GERD: a way to personalized antireflux surgery
Rieder E, Riegler M, Simic AP, Skrobic OM, Bonavina L, Gurski R, Paireder M, Castell DO, Schoppmann SF.
Ann N Y Acad Sci. 2018 May 17. doi: 10.1111/nyas.13851. IF: 4,27
Electrical Stimulation of the Lower Esophageal Sphincter to Treat Gastroesophageal Reflux After POEM
Rieder E, Paireder M, Kristo I, Schwameis K, Schoppmann SF.
Surg Innov. 2018 Aug;25(4):346-349. doi: 10.1177/1553350618768129. IF: 1,549
MK2 and ETV1 Are Prognostic Factors in Esophageal Adenocarcinomas
Jomrich G, Maroske F, Stieger J, Preusser M, Ilhan-Mutlu A, Winkler D, Kristo I, Paireder M, Schoppmann SF.
J Cancer. 2018 Jan 1;9(3):460-468. doi: 10.7150/jca.22310 IF: 3,249
The modified glasgow prognostic score is an independent prognostic indicator in neoadjuvantly treated adenocarcinoma of the esophagogastric junction
Jomrich G, Hollenstein M, John M, Baierl A, Paireder M, Kristo I, Ilhan-Mutlu A, Asari R, Preusser M, Schoppmann SF.
Oncotarget. 2018 Jan 8;9(6):6968-6976. doi: 10.18632/oncotarget.24087, IF: 5,168
Dysphagia severity is related to the amplitude of distal contractile integral in patients with Jackhammer esophagus
Kristo I, Schwameis K, Paireder M, Jomrich G, Kainz A, Schoppmann SF.
Neurogastroenterol Motil. 2018 May;30(5):e13276. doi: 10.1111/nmo.13276, IF: 3,842
Radiofrequency ablation in patients with large cervical heterotopic gastric mucosa and globus sensation: closing the treatment gap
Ivan Kristo, Erwin Rieder, Matthias Paireder, Katrin Schwameis, Gerd Jomrich, Werner Dolak, Thomas Parzefall, Martin Riegler, Reza Asari, Sebastian F. Schoppmann
Dig Endosc. 2017 Sep 7. doi: 10.1111/den.12959
External validation of the NUn score for predicting anastomotic leakage after oesophageal resection
Matthias Paireder, MD; Gerd Jomrich, MD; Reza Asari, MD; Ivan Kristo, MD; Andreas Gleiss, PhD; Matthias Preusser, MD; Sebastian F. Schoppmann, MD.
Sci Rep. 2017 Aug 29;7(1):9725. doi: 10.1038/s41598-017-10084-9., IF: 4,122
Comparison of Inflammation-Based Prognostic Scores in a Cohort of Patients with Resectable Esophageal Cancer
Jomrich G, Paireder M, Gleiss A, Kristo I, Harpain L, Schoppmann SF.
Gastroenterology Research and Practice Volume 2017 – Jun 27 2017
Expression of Programmed Cell Death Protein 1 by Tumor-Infiltrating Lymphocytes and Tumor Cells is Associated with Advances Tumor Stage in Patients with Esophageal Adenocarcinoma
Kollmann D, Ignatova D, Jedamzik J, Chang YT, Jomrich G, Paireder M, Kristo I, Kazakov D, Michal M, Cozzio A, Hoetzenecker W, Schatton T, Asari R, Preusser M, Guenova E, Schoppmann SF.
Ann Surg Oncol. 2017 Apr 20.
Impact of sarcopenia on outcome in patients with esophageal resection following neoadjuvant chemotherapy for esophageal cancer
Matthias Paireder, MD; Reza Asari, MD; Ivan Kristo, MD; Erwin Rieder, MD; Dietmar Tamandl, MD; Ahmed Ba-Ssalamah, MD; Sebastian F. Schoppmann, MD
Eur J Surg Oncol. 2017 Feb;43(2):478-484
Endoscopic stent suture fixation for prevention of esophageal stent migration during prolonged dilatation for achalasia treatment
E. Rieder, R. Asari, M. Paireder, J. Lenglinger, S. F. Schoppmann
Dis Esophagus. 2017 Apr 1;30(4):1-6.
Prognostic value of volumetric PET parameters in unresectable and metastatic esophageal cancer
Tamandl D, Ta J, Schmid R, Preusser M, Paireder M, Schoppmann SF, Haug A, Ba-Ssalamah A
Eur J Radiol. 2016 Mar, (85)3:540-5:Epub 2016 Jan 12
Markers of sarcopenia quantified by computed tomography predict adverse long-term outcome in patients with resected oesophageal or gastro-oesophageal junction cancer
Tamandl D, Paireder M, Asari R, Baltzer PA, Schoppmann SF, Ba-ssalamah A.
Eur Radiol. 2015 Sep 3.
Die Laparoskopische Chirurgie
Paireder M, Schoppmann SF
In 11. Auflage Des Blockbuchs „Ernährung Und Verdauung“ Im Facultas Universitätsverlag
Change In Volume Parameters Induced By Neoadjuvant Chemotherapy Provide Accurate Prediction Of Overall Survival After Resection In Patients With Oesophageal Cancer
Tamandl D, Gore RM, Fueger B, Kinsperger P, Hejna M, Paireder M, Haug A, Schoppmann SF, Ba-Ssalamah A
Eur Radiol 2015 Jun 5
Ösophaguskarzinom: Österreich Im Klassifikationsdilemma
Paireder M, Schoppmann SF
In Krebs:Hilfe! 1:2015
Stromal Expression Of Carbonic Anhydrase IX In Esophageal Cancer
Jomrich G, Jesch B, Birner P, Schwameis K, Paireder M, Asari R, Schoppmann SF
Clin Transl Oncol. 2014 Apr 16
Oncostatin M-Enhanced Vascular Endothelial Growth Factor Expression In Human Vascular Smooth Muscle Cells Involves PI3K-, P38 MAPK-, Erk1/2- And STAT1/STAT3-Dependent Pathways And Is Attenuated By Interferon-Γ
Demyanets S, Kaun C, Rychli K, Pfaffenberger S, Kastl SP, Hohensinner PJ, Rega G, Katsaros KM, Afonyushkin T, Bochkov VN, Paireder M, Huk I, Maurer G, Huber K, Wojta J.
Basic Res Cardiol. 2011 Mar;106(2):217-31. Epub 2010 Dec 21.
Unexpected Low Incidence Of Vertebral Fractures In Heart Transplant Recipients: Analysis Of Bone Turnover
Kerschan-Schindl K, Ruzicka M, Mahr S, Paireder M, Krestan C, Gleiss A, Bieglmayer C, Fialka-Moser V, Pacher R, Grimm M, Pietschmann P.
Transpl Int. 2008 Mar;21(3):255-62. Epub 2007 Nov 26.
Recent Trends In Heart Transplantation: The University Of Vienna Experience
Aliabadi A, Sandner S, Bunzel B, Dunkler D, Mahr S, Paireder M, Zimpfer D, Rödler S, Herics R, Rajek A, Wieselthaler G, Hülsmann M, Wollenek G, Weigel G, Salzer-Muhar U, Wolner E, Grimm M And Zuckermann A.
Clin Transpl 2007:81-97